U.S.-based $Pfizer (PFE.US)$ Covid vaccine, developed in con...

U.S.-based $Pfizer (PFE.US)$ Covid vaccine, developed in conjunction with German partner BioNTech, could be authorized for use in kids 5-11 as soon as next month, according to two sources familiar with the situation who spoke to Reuters. Pfizer is expected to have enough study data by then to submit an application for emergency use to the FDA. The two-dose Pfizer shot is already on emergency use for adolescents 12-15 and full approval for people 16 and older.